- MyIllumina
- Tools
VeraCode Technology: GoldenGate Genotyping Automation Upgrade
Automating GoldenGate Genotyping Assays on the BeadXpress Reader streamlines the workflow and reduces errors. Illumina Robot Control Software combined with the Tecan Freedom EVO 150 liquid handler provides easy automation of the pre- and post-PCR steps in the genotyping protocol.
- The GoldenGate Genotyping Automation Upgrade includes pre- and post-PCR automation software for qualified existing Tecan Freedom EVO or Tecan Genesis RSP liquid handlers. Simultaneous installation of both Tecan and Illumina automation software is required.
- The GoldenGate Genotyping Automation package includes a Tecan Freedom EVO 150 liquid handler equipped to run the pre- or post-PCR GoldenGate Assay protocols and a PC workstation programmed with Illumina's Robot Control software. Installation, training, and a one-year warranty are included. Available in 110V and 220V.
Custom Low- to Mid-plex Genotyping
For profiling and validation studies requiring low to mid-plex genotyping, Illumina provides customized solutions that allow researchers to optimize the number of loci per sample and throughput level to best suit their study goals. Custom assay panels can be easily developed for any species and deployed with either BeadArray or Veracode technology.
More...
Innovative technologies
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
© 2012 Illumina, Inc. All rights reserved.